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ABSTRACT
We studied the suitability of in vitro dialysis with polyacrylonitrile (PAN) membranes to remove small amounts 
of interleukin-1(3 (IL- lp) and tumor necrosis factor (TNF) from plasma to be used as diluent for the standards 
in radioimmunoassays (RIA). Incubation o f PAN membrane fragments with radiolabeled IL-1(3 or TNF 
yielded a significant binding of both cytokines to the membrane (percentage of membrane-bound cytokine after 
incubation in saline or plasma was 14-17% and 23-46% , respectively). Dialysis of plasma (containing radiola­
beled cytokine) against plasma (initially devoid of cytokine) resulted in a binding percentage of IL-1|3 and TNF 
to the PAN membranes of 44 and 28%, respectively. When plasma was dialyzed against saline the percentage 
of membrane-bound IL-1(3 and TNF was 63 and 37%, respectively. After dialysis of plasma against either 
plasma or saline the percentage IL-lfS recovered from the dialysate was approximately 16% in contrast with 
1-2% TNF. The results confirm the capacity of in vitro dialysis with PAN membranes to remove IL-ip and to a 
lesser extent TNF from plasma. Removal is most marked in the first minutes of dialysis (suggesting saturation 
of the membrane) and less effective for TNF due to its low diffusion across the membrane.
INTRODUCTION
In radioim munoassays, the selection o f an appropriate diluent for the standards is essential. To avoid loss o f parallelism  and 
to improve sensitivity, the diluent should possess a matrix sim ­
ilar to the sam ple. In the assay o f circulating cytokines as 
interleukin-lp  (IL-1(3) and tumor necrosis factor (T N F), cyto­
kine-free plasma should preferably be used as d iluent. As nor­
mal pooled plasma usually contains variable am ounts o f these 
cytokines, its purification before use as diluent for the standards 
is indicated.
Previous studies by Lonnemann et al. (1 ,2 ) have shown that 
in vitro dialysis with polyacrylonitrile (PAN) m em branes can 
remove IL -l and TN F from protein-free tissue culture m edium 
or whole blood. This prompted us to evaluate the suitability of 
in vitro dialysis for the depletion o f cytokines from plasm a to be 
used as diluent in cytokine radioim m unoassays. W hether d ialy­
sis procedures are able to effectively remove circulating IL - ip  
and TN F or not could also be important in clinical situations 
such as renal failure, septic shock, and adult respiratory distress 
syndrom e (ARDS) where dialysis or continuous arteriovenous 
hém ofiltration (CAVH) is often used as therapeutic measure.
MATERIALS AND METHODS
Io c lin a tio n  o f  h u m a n  / L - / ß  a n d  T N F
Recom binant hum an IL -lß  (kindly provided by Glaxo, 
Geneva, Sw itzerland) and TNF (kindly provided by Dr. G .R. 
Adolf, Boehringer, Vienna, Austria) were labeled with a m odi­
fication of the chloramine-T method as described elsewhere (5 
jxg o f protein was labeled with 0.5 mCi 125I) (3). Free iodine
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was removed by Sepliadex G-25 filtration (Pharm acia, Upsala, 
Sweden) and the labeled cytokines were stored at 4°C for up to 2 
m onths.
Prior to use, any rem aining free iodine w as again removed by 
Sephadex G-25 M colum n chrom atography. Fractions were 
collected and two peaks o f l25I activity w ere found. Fractions in 
the first peak containing l25I-bound cytokine were used.
S D S -P A G E
Sodium  dodecyl sulfate-polyacrylam ide gel electrophoresis 
(SDS-PAGE) was carried oul to screen the radiolabeled cyto­
kines for the presence o f polymers or decay products. Samples 
containing 20,000 cpm o f radiolabeled IL - ip ,  T N F, and cali­
bration markers (14, 24, and 60 kDa) were diluted with buffer 
containing sodium dodecyl sulfate (SDS). A discontinuous 
9 -1 3 %  separation gel and a 4 .5%  stacking gel were used. The 
gei w as stained with Coom assie Brilliant Blue to estim ate the 
m olecular weight o f the samples by comparison with the molec­
ular weight calibration markers. Dried gels were subjected to 
autoradiography using Kodak films (Kodak X -O M A T ®  AR).
The relative amount o f radioactivity in each lane was esti­
mated by densitometric scanning (Ultroscan XL laser densitom ­
eter, Pharm acia, Upsala, Sweden).
In c u b a tio n  o f  P A N  m e m b ra n e  fr a g m e n ts  w ith  
ra d io la b e le d  /L-7(3 o r  T N F
PAN membranes removed from a new dialyzer w ere cut in 
fragm ents and rinsed with saline. Incubation was performed in 
polystyrene Petri dishes (50 mm diam eter; N unc, Denm ark) and 
in cham bers previously described as the Teflon film dish. This 
film dish consists o f a reusable aluminum holder with a Teflon 
ring (inner diam eter 35 mm) in which a m em brane can be 
m ounted (4).
In the Petri dishes, PAN membrane fragm ents o f  13.5 cm2 
were immersed in the fluid phase. In the film dish only one 
surface of the membrane fragment (9.62 cm 2) was in contact 
with the fluid phase. Bach Petri dish and film dish was filled 
with 4  ml human plasma or saline to which l25I-Iabeled IL -ip  
or T N F was added (approximately 1000 to 200,000 cpm ). After
6 h shaking incubation at room tem perature, radioactivity in the 
fluid phase and adhered to the m embrane was determ ined.
T he results are expressed as percentage o f radioactivity re­
covered after incubation. The sum of radioactivity recovered in 
the fluid phase and mem brane after correction for blanks, was 
set at 100%.
In  v itro  d ia ly s is
A plate dialyzer with polyacrylonitrile (PAN) mem brane 
(AN 69s; Biospal SCU/CAVH Al-U Kit, Hospal NL 5400 AC 
Uden, The Netherlands) was used. Dialysis was perform ed in a 
closed-loop dialysis circuit as shown in Fig. 1.
Both blood and dialysate com partm ents were rinsed with 2 
liters o f  pyrogen-free saline and flushed with air before filling. 
To avoid gradients across the m em brane, dialysis o f  plasma 
against plasma was perform ed in six experim ents; frozen
Q g  = 100 m l/m in Qn s  100 ml/min
FIG . 1. Diagram o f in vitro dialysis circuit. Q B and Q D, flow 
in blood and dialysate com partm ent. M ean fill volumes o f the 
blood and dialysate com partm ent were 117 and 100 ml, respec­
tively.
plasma from the blood bank was thawed and used to fill both 
compartments. The blood com partm ent contained l25I-labelcd 
recombinant human IL -ip  or T N F (approxim ately 104 cpm /m l 
plasma equivalent to less than 30 ng per dialysis), while the 
plasma in the dialysate com partm ent did not contain radio la­
beled cytokine. Dialysis o f plasma against saline was per­
formed in two experiments: the blood com partm ent contained 
plasma with radiolabeled IL -ip  o r TNF and the dialysate com ­
partment was filled with saline free of radiolabeled cytokine. 
The solutions in both com partm ents were circulated for 1 h in a 
countercurrent manner at a flow rate o f 100 m l/m in. The d ialy­
sis was performed under sterile conditions at room  tem perature. 
To determine time-dependent removal o f the cytokines, sam ­
ples (0.5 ml) were drawn every 5 min from both com partm ents. 
After dilution with 2 ml saline the samples were treated with an 
equal volume of 20% trichloroacetic acid (TCA ), centrifuged, 
and the precipitates measured in a gamm a counter. In all exper­
iments, the non-TCA precipitable radioactivity during the dial­
ysis procedure was negligible (< 5 % ). The percentage o f TCA 
precipitable radioactivity in the sam ples after correction for 
blank represents cytokine bound l25I. (Radioactivity in the sam ­
ple from the blood compartment before dialysis was set at 
100%.)
R ecovery  o f  ra d io la b e le d  c y to k in e  f r o m  d ia ly ze r  
co m partm en ts a n d  P A N  m e m b ra n es  a f te r  d ia ly s is
After 1 h of circulation as described above, the dialyzer was 
emptied by flushing air. The void volumes from both com part­
ments were collected separately and the radiolabeled cytokine 
present in each compartment was calculated.
After rinsing the system with saline, the PAN m em branes 
were mechanically removed and the m em brane-bound rad ioac­
tivity was determined before and after a washing step with 0.1 % 
Triton X-100. Results are expressed as percentage of radioac­
tivity recovered from dialyzer and m em branes. The total
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F IG . 2. R ecovery o f radiolabeled IL -ip  and TN F after incu­
bation with PA N m em brane fragments. Results are expressed in 
percentage o f radiolabeled cytokine recovered from the fluid 
phase (plasm a o r saline) and mem brane fragment after incuba­
tion. Each bar represents 8 experiments (mean ±  SD). The sum 
o f cpm  in fluid phase and m embrane fragm ent after blank sub­
traction was sel at 100%. (A) Incubation in Petri dishes. (B) 
Incubation in film  dishes.
am ount o f radioactivity  initially added to the blood compart­
m ent was set at 100%. Results are corrected for blanks.
RESULTS
In c u b a tio n  o f  P A N  m e m b r a n e  f r a g m e n ts  w ith  
r a d io la b e le d  I L - I  a n d  T N F
Results o f incubation of PAN mem brane fragments in Petri 
dishes are show n in Fig. 2A. The recovery of radiolabeled 
1L-I(3 in the fluid phase was 85.8%  (SD ±  14.2) after incuba­
tion in plasm a (n = 8) and 67.4%  (SD ±  3.2) after incubation 
in saline (n =  8). Consequently the m em brane-bound radioac­
tivity was 14.1 and 32 .6% , respectively.
Sim ilar experim ents with TN F yielded a recovery in the fluid 
phase o f  84 .6%  (SD ±  1.1) (n = 8) and 73.3%  (SD ±  9.7) 
(n =  8) after incubation with plasma or saline, respectively. 
The rem aining m em brane-bound activity was 15.4 and 26.7% 
for plasm a and saline incubation, respectively.
W hen incubation was perform ed in the film dishes (Fig. 2B), 
the percentage o f  IL - ip  recovered in the fluid phase was 83%) 
(SD ±  3.7) for plasm a (n = 8) and 76.7%  (SD ±  4.3) for sa­
line (/i =  8) incubation. The percentage o f membrane-bound 
IL-1|3 was 16.9 and 2 3 .2% , respectively. Sim ilar experiments 
with T N F yielded a recovery in the fluid phase o f 83.5% 
(SD ± 7 .1 )  for plasm a (n = 8) and 54.3%  (SD ±  11.3) for 
saline (n =  8) incubation while the percentage o f membrane- 
bound T N F w as 16.5 and 45.7%  after incubation in plasma and 
saline, respectively.
A fter incubation, the Petri dishes and film dishes did not 
contain radioactivity  above the background levels. The mem­
brane-bound radioactivity  measured both before and after wash­
ing twice with saline and 0.1%  Triton X-100, respectively, was 
essentially unchanged.
T im e -d e p e n d e n t re m o v a l o f  ra d io la b e le d  I L - 1 (3 a n d  
T N F  d u rin g  in v itro  d ia ly s is  w ith  P A N  m e m b ra n e s
The distribution of 12iil-labeled IL -1 (3 over both com part­
ments during 1 h o f in vitro dialysis is shown in Fig. 3. W hen 
dialysis o f plasma against plasma was perform ed (n =  3), the 
am ount o f  l25I-labeled IL -1 (3 in the blood compartment fell 
rather abruptly to 54.8%  in the first minutes and decreased 
further gradually to 36.6%  o f the initial value after 1 h. In the 
dialysate, which initially did not Contain radiolabeled cytokine, 
l2SI-labelcd IL - ip  gradually reached a plateau. A fter 1 h, 
14.3% o f l25I-lubeled IL -1 p had crossed the hemodialysis 
m em brane and was present in the dialysate compartment 
(Fig. 3A).
Dialysis of plasma against saline (n =  1) yielded an even 
more pronounced decrease in radioactive IL -1 (3 content o f the 
blood com partm ent in the first minutes with a concentration of 
19.5 and 9.1%  in blood compartment and dialysate, respec­
tively, after 1 h dialysis (Fig. 3B).
The results o f sim ilar experiments performed with l25l-la- 
beled T N F are shown in Fig. 4. The amount o f 125I-labeled 
TN F in the blood compartm ent decreased to 67.6 and 64.2%  
after 10 niin dialysis with a final concentration o f 60.5 and 
69.5%  after I h dialysis o f plasma against plasma (Fig. 4A) and 
saline (Fig. 4B), respectively. In contrast with IL-1 p, less than 
2%  radiolabeled TNF was found in the dialysate after I h 
dialysis either against plasma or saline.
R e c o v e ry  o f  ra d io la b e le d  cy to k in e  fr o m  d ia ly ze r  
c o m p a r tm e n ts  a n d  P A N  m em b ra n es  a fte r  d ia lysis
From the initial amount o f l25l-labeled IL -1 (3 present in the 
blood compartment an average of 84,5% was recovered after 1 h
F IG S . 3 and 4 . Tim e-dependent distribution of l25I-labeled 
cytokine during in vitro dialysis with PAN membranes. Hori­
zontal axis: m inutes o f  dialysis. Percentage radiolabeled cyto­
kine in the samples o f  the blood compartment (open sym bols), 
o r dialysate (closed symbols). Fig. 3. Results for l25l-labeled 
IL -1 p . Fig. 4. Results for l25I-labeled TNF. (A) Dialysis o f 
plasm a against plasma (« =  3 for each cytokine). (B) Dialysis 
o f  plasm a against saline (/? =  I for each cytokine).
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F IG . 5. Recovery of l25I-labeled cytokine from  the blood and dialysate compartments and m em branes o f the PAN dialyzer after 
1 h o f in vitro dialysis. The total am ount o f radiolabeled cytokine present in the blood compartm ent before dialysis was set at 100%. 
Horizontal indicates dialysis o f plasm a against either plasm a or saline. The six bars on the left represent recovery o f l25I-labeled 
IL -1 p , the six bars on the right recovery of 125I-labeled TN F.
dialysis o f plasma against plasma (n =  3): 24 .7%  w as found 
in the blood com partm ent, 15.3% in the dialysate, and 44.5%  
was m embrane-bound. Dialysis o f plasm a against saline 
(n =  I) yielded a total recovery of 95.8%  radiolabeled IL -ip  
distributed as follows: 16.6% was recovered from  blood com ­
partment, 16.1% from dialysate, and 63.1%  from  m em branes 
(Fig. 5).
In sim ilar experiments with l25l-labeled T N F an average o f 
84% was recovered after 1 h dialysis o f p lasm a against plasm a 
(« =  3): 54.2%  was found in the blood com partm ent, 1.7%  in 
the dialysate, and 28.1%  was m em brane-bound. D ialysis of 
plasma against saline {it -  1) yielded a total recovery o f 87.9%  
TN F with the following distribution: 47 .6%  from  blood com ­
partm ent, 2.6%  from dialysate, and 37.7%  from  m em branes 
(Fig. 5).
The radioactivity not recovered in these experim ents is partly 
due to loss in sam pling (mean 5%); the rest probably rem ained 
bound to the nonmembrane parts o f the dialyzer and the tubing.
In all experiments the saline used to rinse the dialyzer after 
dialysis contained no radioactivity above b lank levels. The 
mem branes recovered from the dialyzer w ere washed w ith T ri­
ton X-100; only 1.4 and 1.9% (respectively, for I L - ip  and 
TNF) o f the mem brane-bound radioactivity was released after 
the washing step.
S D S -P A G E
Results of autoradiography after SD S-PA G E  o f radiolabeled 
TNF and IL - lp  are shown in Fig. 6, For both T N F and I L - l p  
several weak bands were observed in the m olecular weight 
range o f 65-90  kDa. M ore than 95%  o f  I L - lp  and 80%  o f  TN F 
was present in a m olecular weight range under 20 kD a. Two 
strong bands with m olecular weights around 40 and 55 kDa 
were present only in the T N F sam ple and com prised 19% o f the 
total radioactivity as revealed by densitom etric scanning. These 
probably represent TN F oligom ers o r com plexes o f T N F  and 
other plasm a proteins. Sam ples from  the dialysate com partm ent 
were not analyzed in view of the low recovery T N F in the 
dialysate compartment.
DISCUSSION
In the present study we confirm ed previous findings o f  a 
significant binding of IL -lp  to PAN m em branes (1,2) and ex­
tended these observations to T N F, using sm all amounts of 
these cytokines such as are likely to be found in pooled plasma. 
The removal of IL - la  was not studied since this cytokine is 
known to be mostly bound to cell m em brane and not circulat­
ing (5).
Incubation of PAN m em brane fragments either in Petri 
dishes or film dishes resulted in a 14-17%  of m em brane-bound
kDa
«  TW ti
F IG . 6. Autoradiogram of a native polyacrylam ide gel. The 
numbers on the right show the migration o f  m olecular w eight 
markers.
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IL - ip  or TNF when these cytokincs were diluted with plasma. 
W hen diluted with saline, binding increased almost 2-fold inde­
pendent o f the cytokine studied. This suggests that cytokine 
binding to the m em brane is not specific and probably has to 
compete with other plasm a proteins. In general, experiments 
with membrane fragm ents yielded a lower percentage of m em ­
brane-bound radioactivity than in vitro dialysis. This can be 
explained by the differences in surface exposed, the stationary 
versus recirculatory incubation, and the diffusive clearance (in 
addition to adsorption) that takes place during dialysis. In view 
o f these results, in vitro  incubation o f plasma with PAN m em ­
branes seems less suitable than in vitro dialysis to remove IL -1 (3 
and TN F from plasm a.
The results o f the in vitro dialysis with PAN membrane 
dem onstrate effective removal from plasma o f a significant 
amount o fIL -1 P ; the removal of TN F is less pronounced.
W hen the tim e-dependent distribution o f cytokine during di­
alysis is exam ined, the decrease o f radiolabeled cytokine con­
tent in the blood com partm ent is most marked during the first 
m inutes of dialysis and is more pronounced for IL-1 (3 than for 
TNF. The plateau reached thereafter suggests saturation of the 
PAN mem brane either by cytokines themselves or, more prob­
ably, by adsorption o f other plasma proteins. In the dialysate 
compartm ent IL-1(3 appears gradually, in contrast with TNF, 
which hardly diffuses through the membranes.
After 1 h dialysis, the amount of TN F remaining in the blood 
compartm ent is m ore than 2-fold higher for IL -1 p while the 
amount recovered from the dialysate is 6-fold higher for IL -lp  
than for TNF. This underscores the low capacity of TN F to 
cross the PAN m em branes.
Dialysis o f plasm a against saline yields a higher cytokine 
binding to the m em brane (specially for IL -1P) than dialysis of 
plasma against plasm a. This suggests (hat the presence o f saline 
in the dialysate com partm ent leads to an increase in the passage 
o f the cytokines through the m embrane and in the binding to the 
dialysate side o f the m em brane, which is not in contact plasma 
proteins.
Taken together the results show that removal of IL -1 p from 
the blood com partm ent is due to adsorption to the membrane 
and filtration to the dialysate com partm ent, while removal of 
TN F is less effective and mostly due to adsorption. Sim ilar 
results have been recently reported by Lonnemann et al. (6). 
The low degree o f  diffusion o f TNF through the PAN mem­
brane was not unexpected. The PAN membrane has a high 
transmittance coefficient for m olecular sizes between 1, 3,  and 
44 kD a (7), which should allow filtration of both cytokines in 
monomeric form (17 kDa), however, active human natural and 
recombinant TN F is known to consist o f trimers (8) and dimers
(9). O ur data on SD S-PA G E of sam ples containing recom bi­
nant radiolabeled T N F  confirm ed the presence of TN F aggre­
gates. Besides by m olecular size exclusion, other factors such 
as unspecific adsorption o f plasma proteins to the membrane 
which could com plex with T N F, the tertiary structure o f the 
TNF m olecule, and the negative surface charge of the PAN 
mem brane, may also play a role in the low filtration o f TN F 
through the m em brane.
The proportion o f cytokine that remains membrane-bound 
after I h dialysis is low er for TNF than for IL -1 p . These results 
contrast with the sim ilar mem brane binding observed for both 
cytokines after incubation with mem brane fragments in plasma.
An explanation could be that due to the low TN F fraction 
present in the dialysate com partm ent, the PAN mem brane is 
mainly exposed to T N F in the blood com partm ent while expo­
sure to IL-1 p  (which crosses the membrane readily) takes place 
at both com partm ents.
This lower m em brane binding of TNF is also in contrast with 
a recent study by Lonnem ann et al. (6). In that study human 
blood w ith recom binant or natural TN F or IL-I was circulated 
against saline and a higher m embrane binding was found for 
TN F than for IL-1. In that study, the amount o f membrane- 
bound cytokine was calculated from the difference between the 
amount added and recovered from both dialyzer compartm ents, 
while our data show  a direct measurement o f the membrane- 
bound cytokine; furthermore it is possible that a greater TNF 
load in the blood com partm ent or a greater proportion o f  mono­
meric T N F  could explain the differences.
A lthough we did not investigate removal o f larger quantities 
of radiolabeled cytokine, the early saturation o f the membrane 
(suggested by the plateau invariably present in the blood com ­
partm ent after som e m inutes dialysis) with the relative low 
cytokine load, which we investigated, could imply decreasing 
efficiency of the cytokine removal with increasing amounts of 
cytokine. Lonnemann et al. (6), however, found sim ilar per­
centage of cytokine absorbed to the PAN membrane during 
in vitro  dialysis with increasing cytokine load (75 ng and 1.5 
|xg). T ogether with our data, this suggests that after some m in­
utes o f  dialysis, an equilibration between the circulating cyto­
kine and the fraction that is adsorbed to the membrane has taken 
place, and to reduce further the circulating load the use o f a new 
dialyzcr would be necessary.
The m echanism  of binding IL-1P and TNF by PAN is not 
elucidated here; binding curves sim ilar to ours have been re­
ported for com plem ent components and cytochrome c (10), and 
therefore we do not believe that the binding is cytokine-spe­
cific. W ashing the PAN membranes with saline and 0.1%  Tri­
ton X-100 did not lead to significant release o f membrane- 
bound cytokine.
In vitro  dialysis with PAN membranes seems to be a useful 
m ethod to remove IL-1P from plasma (specially with dialysis of 
plasm a against saline) to be used for standards in immunoas­
says. Removal o f  TN F is less effective and other methods such 
as affinity chrom atography ( I I )  may prove more suitable.
O ur results may also have implications for clinical settings 
where these dialyzers are used. Continuous arteriovenous he- 
m ofiltration (CAVH) used as adjunctive therapy in septic shock 
and ARDS is aimed to remove deleterious exogenous and en­
dogenous m ediators (such as TN F and IL-1). These cytokines 
are probably associated with acute and chronic complications of 
in vivo  hem odialysis (12,13). The presumed rapid saturation of 
these m em branes, the low filtration o f T N F, and the induction 
o f cytokine production that may occur during in vivo dialysis 
(1 4 -2 0 ) casts doubts on the usefulness o f such membranes for 
removal o f  these cytokines in vivo.
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